Aviva commits additional £150 million to Aviva Ventures

Aviva is committing a further £150 million to its corporate venture capital fund, Aviva Ventures. The fund will focus on delivering returns through investments into early stage businesses that bring Aviva new opportunities and insights into emerging technology and customer trends.

Aviva is also announcing the new fund’s first investment, which invested £1.5 million in Scan.com, a business helping individuals and organizations book diagnostic scans such as MRI, ultrasounds and x-rays.

“Innovation is central to Aviva’s strategy and our ambition to deliver great outcomes for our customers. The £150m commitment to Aviva Ventures will be used to make early stage investments in promising young digital and tech firms that also provide us with insight on emerging technology and consumer trends. Our investment in Scan.com is a statement of our intent – they are growing rapidly, have a unique customer proposition and are already leading the way on medical imaging services in the UK. We are really excited to support Scan.com’s development and growth.” – Ben Luckett, chief innovation officer at Aviva.

“We are thrilled to have such strong support from Aviva as we continue to build Scan.com across the UK. The capital will be used to continue to improve access to diagnostic imaging and medical screening exams, through our consumer facing marketplace and application programming interfaces (API). This round would not have been possible without the incredible effort and tenacity shown by our entire team, who have built Scan.com at such a fast pace in what is traditionally a very slow-moving industry.” – Charlie Bullock, co-founder and CEO of Scan.com.